Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
Cancer Sci. 2022 May;113(5):1868-1879. doi: 10.1111/cas.15326. Epub 2022 Apr 5.
Pancreatic adenocarcinoma (PAAD) remains an extremely fatal malignancy with a high mortality rate worldwide. This study focuses on the roles of ubiquitin-specific peptidase 10 (USP10) and cysteine rich angiogenic inducer 61 (Cyr61) in macrophage polarization, immune escape, and metastasis of PAAD. USP10 showed a positive correlation with Yes1 associated transcriptional regulator (YAP1), which, according to the TCGA-PAAD database, is highly expressed in PAAD and indicates poor patient prognosis. USP10 knockdown increased ubiquitination and degradation of YAP1, which further decreased the programmed cell death ligand 1 (PD-L1) and Galectin-9 expression, suppressed immune escape, and reduced the proliferation and metastasis of PAAD cells in vitro and in vivo. Cyr61, a downstream factor of YAP1, was overexpressed in PAAD cells after USP10 silencing for rescue experiments. Overexpression of Cyr61 restored the PD-L1 and Galectin-9 expression in cells and triggered M2 polarization of macrophages, which enhanced the immune escape and maintained the proliferation and metastasis ability of PAAD cells. In conclusion, this work demonstrates that USP10 inhibits YAP1 ubiquitination and degradation to promote Cyr61 expression, which induces immune escape and promotes growth and metastasis of PAAD.
胰腺导管腺癌(PAAD)仍然是一种极其致命的恶性肿瘤,全球死亡率很高。本研究专注于泛素特异性肽酶 10(USP10)和富含半胱氨酸的血管生成诱导因子 61(Cyr61)在 PAAD 中巨噬细胞极化、免疫逃逸和转移中的作用。USP10 与 Yes1 相关转录调节剂(YAP1)呈正相关,根据 TCGA-PAAD 数据库,YAP1 在 PAAD 中高表达,提示患者预后不良。USP10 敲低增加了 YAP1 的泛素化和降解,进一步降低了程序性细胞死亡配体 1(PD-L1)和半乳糖凝集素 9 的表达,抑制了免疫逃逸,并减少了 PAAD 细胞在体外和体内的增殖和转移。Cyr61 是 YAP1 的下游因子,USP10 沉默后的 PAAD 细胞中过表达用于挽救实验。Cyr61 的过表达恢复了细胞中 PD-L1 和半乳糖凝集素 9 的表达,并触发了巨噬细胞的 M2 极化,增强了免疫逃逸,并维持了 PAAD 细胞的增殖和转移能力。总之,这项工作表明 USP10 抑制 YAP1 的泛素化和降解,以促进 Cyr61 的表达,从而诱导免疫逃逸并促进 PAAD 的生长和转移。